ProQR Therapeutics PRQR
NASDAQ PRQR
$1.68 +0.03 (+1.82%)
As of: Sep 30, 2026 · 11:39 AM EDT

ProQR Therapeutics (PRQR) Non-Current Assets (2013 - 2026)

Updated

ProQR Therapeutics (PRQR) recorded Non-Current Assets of $13.86 million in the quarter ended Jun 30, 2026, down 7.7% from $15.01 million a year earlier and down 1.8% from the prior quarter.

Analysis

ProQR Therapeutics (PRQR) Non-Current Assets (2013 - 2026) Analysis & Trends

As of Dec 31, 2025, ProQR Therapeutics reported Non-Current Assets of $14.27 million, down 6.6% from the prior year.

  • Annual Non-Current Assets has a five-year compound annual growth rate of -7.8% (years ended Dec 2020 to Dec 2025).
  • Across earlier years, Non-Current Assets came in at $15.28 million in the year ended Dec 31, 2024 (-16.4%), $18.28 million in the year ended Dec 31, 2023 (+2.9%), $17.77 million in the year ended Dec 31, 2022 (-17.0%) and $21.41 million in the year ended Dec 31, 2021 (+0.3%).
  • The figure for the quarter ended Jun 30, 2026 is the lowest quarterly Non-Current Assets since the quarter ended Jun 30, 2020.
  • On a year-over-year basis, Non-Current Assets has declined for nine consecutive quarters, with an average decline of 10.5% over the last eight quarters.
  • Peak year-over-year performance for Non-Current Assets in the last five years was growth of 6.2% in the quarter ended Sep 30, 2023, against a decline of 21.2% in the quarter ended Mar 31, 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $14.11 million (quarter ended Mar 31, 2026), $14.7 million (quarter ended Dec 31, 2025) and $15.22 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 141.29 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 101.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 125.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 94.68 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 87.87 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 60.68 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 35.42 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 159.77 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 14.88 Bn
10 ProQR Therapeutics 173.85 Mn -289.75 Mn - 13.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 13.86 Mn
Mar 31, 2026 14.11 Mn
Dec 31, 2025 14.70 Mn
Sep 30, 2025 15.22 Mn
Jun 30, 2025 15.01 Mn
Mar 31, 2025 14.31 Mn
Dec 31, 2024 15.08 Mn
Sep 30, 2024 15.85 Mn
Jun 30, 2024 17.54 Mn
Mar 31, 2024 18.17 Mn
Dec 31, 2023 18.18 Mn
Sep 30, 2023 18.88 Mn
Jun 30, 2023 18.34 Mn
Mar 31, 2023 17.60 Mn
Dec 31, 2022 17.20 Mn
Sep 30, 2022 17.77 Mn
Jun 30, 2022 19.20 Mn
Mar 31, 2022 19.93 Mn
Dec 31, 2021 20.70 Mn
Sep 30, 2021 21.55 Mn
API Access

ProQR Therapeutics Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=PRQR&period=max&api_key=YOUR_API_KEY